Sensitizing tumor cells to radiotherapy
Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer worldwide. Tumor resistance to radio- and/or chemotherapy remains a significant clinical problem.
Cancer
Mar 01, 2012 |
5 / 5 (1) |
0
Robotic surgery proves successful, less invasive way to treat HPV-related oral cancer
Over the past few decades, doctors have noted a surprising trend in cancer of the tonsils and base of the tongue. Though oral cancer previously appeared predominantly in elderly patients with a history of tobacco and alcohol ...
Cancer
Mar 01, 2012 |
5 / 5 (2) |
0
Dose-Response link between tanning bed use, skin cancer
(HealthDay) -- Use of tanning beds, especially in high school and college, is associated with an increased risk of skin cancer, according to a study published online Feb. 27 in the Journal of Clinical Oncology.
Cancer
Feb 28, 2012 |
5 / 5 (1) |
0
High VEGF signaling score tied to lung cancer prognosis
(HealthDay) -- A high vascular endothelial growth factor (VEGF) signaling score correlates with good prognosis in patients with early squamous cell carcinoma (SCC) of the lung, according to a study published ...
Cancer
Feb 22, 2012 |
5 / 5 (1) |
0
UK study provides insight into cancer progression
The University of Kentucky has announced that Dr. Daret St. Clair, the James Graham Brown Endowed Chair and professor of toxicology, has published the first comprehensive study that provides insight into the relationship ...
Cancer
Feb 22, 2012 |
5 / 5 (1) |
0
First prospective clinical trial of adaptive radiotherapy for head and neck cancer patients
Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy ...
Cancer
Feb 09, 2012 |
5 / 5 (1) |
0
Combination drug therapy urged to battle lung cancer
Combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC), according to a study by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI).
Cancer
Feb 02, 2012 |
not rated yet |
0
FDA approves new skin cancer drug
A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable ...
Cancer
Feb 01, 2012 |
not rated yet |
0
Four-week vaccination regimen knocks out early breast cancer tumors, researchers find
Researchers at the Perelman School of Medicine at the University of Pennsylvania report that a short course of vaccination with an anti-HER2 dendritic cell vaccine made partly from the patient's own cells triggers a complete ...
Cancer
Jan 30, 2012 |
5 / 5 (4) |
0
|
FDA approves Roche skin cancer drug Erivedge
(AP) -- Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.
Medications
Jan 30, 2012 |
5 / 5 (1) |
0
FDA clears Pfizer drug for advanced kidney cancer
(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
Medications
Jan 27, 2012 |
5 / 5 (2) |
0
Grape seed extract kills head and neck cancer cells, leaves healthy cells unharmed
Nearly 12,000 people will die of head and neck cancer in the United States this year and worldwide cases will exceed half a million.
Cancer
Jan 27, 2012 |
4.8 / 5 (55) |
18
|
Prevalence of oral HPV infection higher among men than women
The overall prevalence of oral human papillomavirus (HPV) infection is approximately 7 percent among men and women ages 14 to 69 years in the United States, while the prevalence among men is higher than among women, according ...
Cancer
Jan 26, 2012 |
not rated yet |
0
Lead blood levels may increase smokers' risk for kidney cancer
Higher than normal levels of lead in the blood may signal a risk two times higher than average of developing renal cell carcinoma in smokers, according to medical researchers.
Cancer
Jan 23, 2012 |
not rated yet |
0
|
Study uncovers mechanism by which melanoma drug accelerates secondary skin cancers
Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer. Now, researchers at UCLA's ...
Cancer
Jan 18, 2012 |
5 / 5 (1) |
0
|
